Monday 16 November 2026
Export KYNB’s income statement to Excel — free account
Kyntra Bio Inc
KYNBKyntra Bio Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.4 million, down 78.3% from fiscal 2024.
- Revenue
- n/m
- EPS
- n/m
- Free cash flow
- n/m
Quarter to June 2026, against a year earlier
3.44
0.15
−4.18%
Follow KYNB
Alert me
Kyntra Bio Inc (KYNB) P/E ratio
As of 13 November 2026, Kyntra Bio Inc (KYNB) trades at a P/E ratio of 0.1×. Over the past ten years it has ranged from 0.0× (September 2025) to 98.1× (December 2019); the current reading is higher than 86% of that period. That is below the Biotechnology industry median of 11.4× and below the Healthcare sector median of 25.3×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.2× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.2× | (0.54%) |
| Mar 2026 | 0.2× | (13.21%) |
| Dec 2025 | 0.2× | (15.71%) |
| Sep 2025 | 0.2× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 98.1×
Ten-year median
0.0×
Current reading's percentile
86
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CTXR Citius Pharmaceuticals, Inc. compare | n/m |
| MCRB Seres Therapeutics, Inc. compare | n/m |
| JSPR Jasper Therapeutics, Inc. compare | n/m |
| ALLR Allarity Therapeutics, Inc. compare | n/m |
| ADAPY Adaptimmune Therapeutics PLC compare | n/m |
| QNTM Quantum Biopharma Ltd. compare | n/m |
| MRKR MARKER THERAPEUTICS, INC. compare | n/m |
| NCEL NewcelX Ltd. compare | n/m |
| KYNB Kyntra Bio Inc | 0.1× |
| Biotechnology industry median | 11.4× |
| Healthcare sector median | 25.3× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)